CEP
CYTK icon

Chicago Equity Partners’s Cytokinetics CYTK Stock Holding History

Chicago Equity Partners’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-118,639
Closed -$1.26M – 705
2019
Q4 		$1.26M Sell
118,639
-28,020
-19% -$288K 0.07% 388
2019
Q3 		$1.67M Buy
146,659
+92,965
+173% +$1.17M 0.08% 362
2019
Q2 		$604K Buy
+53,694
New +$518K 0.03% 660

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Chicago Equity Partners's CYTK Position: Q1 2020 in Review

Chicago Equity Partners sold out of Cytokinetics (CYTK) in Q1 2020, closing a stake of 118,639 shares — an estimated $1.26M sold.

Chicago Equity Partners first reported a position in CYTK in Q2 2019 and held it in 3 quarters. The position peaked at $1.67M in Q3 2019. 147 funds tracked by Wall St. Rank hold CYTK as of Q1 2020.

  • Chicago Equity Partners reported no remaining Cytokinetics position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 118,639 Cytokinetics shares in Q1 2020, an estimated $1.26M.
  • Chicago Equity Partners first reported a position in Cytokinetics in Q2 2019 and held it in 3 quarters.
  • Chicago Equity Partners's Cytokinetics position peaked at $1.67M in Q3 2019.
  • 147 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.